Nuvation Bio NUVB
NYSE NUVB
$5.63 +0.03 (+0.45%)
As of: Sep 29, 2026 · 3:59 PM EDT

Nuvation Bio (NUVB) Research & Development (2020 - 2026)

Updated

Nuvation Bio's Research & Development came in at $30.66 million for Q2 2026, up 12.1% from $27.36 million a year earlier but down 12.5% from the prior quarter.

Analysis

Nuvation Bio (NUVB) Research & Development (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Nuvation Bio reported Research & Development of $128.85 million, up 18.2% year-over-year; for FY2025, it came in at $115.11 million, up 16.1% from FY2024.

  • Research & Development carries a five-year compound annual growth rate of 28.7% (FY2020 to FY2025).
  • Going back by year, Research & Development was $99.12 million in FY2024 (+39.0%), $71.29 million in FY2023 (-18.8%), $87.82 million in FY2022 (+27.2%) and $69.04 million in FY2021 (+111.8%).
  • The five-year range for quarterly Research & Development is $12.84 million (Q1 2024) to $35.05 million (Q1 2026).
  • Year-over-year, Research & Development has increased for four consecutive quarters, with growth averaging 37.6% over the last eight quarters.
  • The fastest year-over-year change in Research & Development over five years came in Q4 2021 (growth of 135.7%), and the weakest in Q2 2023 (a decline of 35.7%).
  • Business Quant data shows NUVB's Research & Development at $35.05 million (Q1 2026), $34.3 million (Q4 2025) and $28.85 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 3.65 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 2.34 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 9.74 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -2.85 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -4.05 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 1.87 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 1.76 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.81 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 993.80 Mn
10 Nuvation Bio 1.94 Bn 1.94 Bn - 30.66 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 30.66 Mn
Mar 31, 2026 35.05 Mn
Dec 31, 2025 34.30 Mn
Sep 30, 2025 28.85 Mn
Jun 30, 2025 27.36 Mn
Mar 31, 2025 24.60 Mn
Dec 31, 2024 29.30 Mn
Sep 30, 2024 27.73 Mn
Jun 30, 2024 29.25 Mn
Mar 31, 2024 12.84 Mn
Dec 31, 2023 15.35 Mn
Sep 30, 2023 18.56 Mn
Jun 30, 2023 18.59 Mn
Mar 31, 2023 18.79 Mn
Dec 31, 2022 16.87 Mn
Sep 30, 2022 21.29 Mn
Jun 30, 2022 28.92 Mn
Mar 31, 2022 20.73 Mn
Dec 31, 2021 22.00 Mn
Sep 30, 2021 17.12 Mn
API Access

Nuvation Bio Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=NUVB&period=max&api_key=YOUR_API_KEY